Workflow
Nasdaq(NDAQ)
icon
Search documents
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in January 2025
The Motley Fool· 2025-02-05 18:58
Although most stocks made forward progress in January, a few of them bucked the bigger trend for understandable reasons.January 2025 was a bullish month for many Nasdaq-listed names. But that wasn't the case for all of them. While the Nasdaq-100 index advanced 2.2% in January, a handful of its constituents (including a market favorite) lost quite a bit of ground. Here they are, from least bad to worst: Monster Beverage (MNST -1.37%): Down 7.3%Comcast (CMCSA 0.85%): Down 10.3%Nvidia (NVDA 3.22%): Down 10.6%E ...
Adia Nutrition Advances Towards OTCQB Uplisting with Third-Party Audit and Provides Roadmap to Listing on Nasdaq Small Cap
GlobeNewswire News Room· 2025-02-05 15:15
WINTER PARK, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), an innovator nutritional products and medical treatments, has announced that through collaboration with Adia’s accountant, Adia has appointed a PCAOB (Public Company Accounting Oversight Board) accounting firm to conduct a comprehensive third-party audit. This strategic move is part of Adia's plan to uplist its shares from the OTC Pink Sheets to the OTCQB Venture Market, aiming to enhance visibility, attract a broade ...
Nasdaq 100 and S&P 500: Futures Drop as Alphabet, AMD, and Apple Weigh on Markets
FX Empire· 2025-02-05 13:00
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Nasdaq 100 Slides as China's Apple Probe and Google's Earnings Miss Shake Market Sentiment
FX Empire· 2025-02-05 10:20
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Nasdaq Jumps Over 1% Despite China's Trade Concerns As Palantir, Spotify Surge: Greed Index Remains In 'Fear' Zone
Benzinga· 2025-02-05 07:41
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone on Tuesday.U.S. stocks settled higher on Tuesday, with the Dow Jones index gaining more than 100 points during the session despite escalating geopolitical tensions and trade uncertainties between the world's two largest economies.China responded to President Donald Trump‘s 10% import tariff with targeted countermeasures, including restrictions on key mineral exports to the ...
Nasdaq Index: Alphabet's Earnings Shock—Stock Drops 6% After Hours on Revenue Miss
FX Empire· 2025-02-04 21:21
EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...
Nasdaq CEO Adena Friedman to Present at the 2025 UBS Financial Services Conference
Globenewswire· 2025-02-04 21:05
NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq’s Investor Relations website: ir.nasdaq.com/events.cfm. Who:Adena Friedman, Chair & CEO, Nasdaq What:2025 UBS Financial Services Conference When:Monday, February 10, 20251:00 PM ET About Nasdaq Nasdaq (Nasdaq: NDAQ) is a global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and in ...
Nasdaq Reports January 2025 Volumes
Globenewswire· 2025-02-04 21:05
NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for January 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About Nasdaq Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. ...
Nasdaq Surges Over 1%; Pfizer Earnings Top Estimates
Benzinga· 2025-02-04 17:21
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.The Dow traded up 0.17% to 44,499.60 while the NASDAQ gained 1.19% to 19,621.76. The S&P 500 also rose, gaining, 0.64% to 6,032.76.Check This Out: Jim Cramer: AutoZone Is A ‘Great’ Stock, Recommends Buying This Energy StockLeading and Lagging SectorsEnergy shares surged by 1.9% on Monday.In trading on Monday, consumer staples shares fell by 0.7%.Top HeadlineOn Tuesday, Pfizer Inc. PFE reported ...
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire News Room· 2025-02-03 21:30
WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective February 1, 2025, the company granted non-qualified stock options to purchase an aggregate of 83,400 shares of its common stock to four new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan. The stock options have an exercise pr ...